173 related articles for article (PubMed ID: 28906339)
21. A Multicompartmental Diffusion Model for Improved Assessment of Whole-Body Diffusion-weighted Imaging Data and Evaluation of Prostate Cancer Bone Metastases.
Conlin CC; Feng CH; Digma LA; Rodríguez-Soto AE; Kuperman JM; Rakow-Penner R; Karow DS; White NS; Seibert TM; Hahn ME; Dale AM
Radiol Imaging Cancer; 2023 Jan; 5(1):e210115. PubMed ID: 36705559
[TBL] [Abstract][Full Text] [Related]
22. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy.
Musio D; De Francesco I; Galdieri A; Marsecano C; Piciocchi A; Napoli A; De Felice F; Tombolini V
Eur J Radiol; 2018 Jan; 98():1-6. PubMed ID: 29279145
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.
Vargas HA; Schor-Bardach R; Long N; Kirzner AN; Cunningham JD; Goldman DA; Moskowitz CS; Sosa RE; Sala E; Panicek DM; Hricak H
Abdom Radiol (NY); 2017 Jan; 42(1):271-277. PubMed ID: 27480976
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
27. Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.
Minutoli F; Pergolizzi S; Blandino A; Mormina E; Amato E; Gaeta M
Radiol Med; 2020 Mar; 125(3):280-287. PubMed ID: 31823293
[TBL] [Abstract][Full Text] [Related]
28. Negative Predictive Value of Prostate Multiparametric Magnetic Resonance Imaging among Men with Negative Prostate Biopsy and Elevated Prostate Specific Antigen: A Clinical Outcome Retrospective Cohort Study.
Lo G; Burton KR; Haider MA; Fleshner N; Finelli A; Ghai S
J Urol; 2019 Dec; 202(6):1159-1165. PubMed ID: 31188731
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
30. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
31. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.
Mussi TC; Martins T; Tachibana A; Mousessian PN; Baroni RH
Int Braz J Urol; 2018; 44(5):882-891. PubMed ID: 30044597
[TBL] [Abstract][Full Text] [Related]
32. 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?
Valerio M; Zini C; Fierro D; Giura F; Colarieti A; Giuliani A; Laghi A; Catalano C; Panebianco V
Eur J Radiol; 2016 Apr; 85(4):790-4. PubMed ID: 26971425
[TBL] [Abstract][Full Text] [Related]
33. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging.
Arita Y; Takahara T; Yoshida S; Kwee TC; Yajima S; Ishii C; Ishii R; Okuda S; Jinzaki M; Fujii Y
Invest Radiol; 2019 Oct; 54(10):638-644. PubMed ID: 31192827
[TBL] [Abstract][Full Text] [Related]
35. Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.
Hermie I; Van Besien J; De Visschere P; Lumen N; Decaestecker K
Eur J Radiol; 2019 May; 114():92-98. PubMed ID: 31005183
[TBL] [Abstract][Full Text] [Related]
36. Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.
Fedorov A; Tuncali K; Panych LP; Fairhurst J; Hassanzadeh E; Seethamraju RT; Tempany CM; Maier SE
Magn Reson Imaging; 2016 Oct; 34(8):1146-54. PubMed ID: 27240900
[TBL] [Abstract][Full Text] [Related]
37. Detection of Prostate Cancer Metastasis by Whole Body Magnetic Resonance Imaging Combined with Bone Scintigraphy and PSA Levels.
An H; Tao N; Li J; Guan Y; Wang W; Wang Y; Wang F
Cell Physiol Biochem; 2016; 40(5):1052-1062. PubMed ID: 27941343
[TBL] [Abstract][Full Text] [Related]
38. Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?
Faletti R; Battisti G; Discalzi A; Grognardi ML; Martinello S; Oderda M; Gontero P; Bergamasco L; Cassinis MC; Fonio P
Abdom Radiol (NY); 2016 May; 41(5):926-33. PubMed ID: 27193791
[TBL] [Abstract][Full Text] [Related]
39. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
Larbi A; Dallaudière B; Pasoglou V; Padhani A; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
Prostate; 2016 Aug; 76(11):1024-33. PubMed ID: 27197649
[TBL] [Abstract][Full Text] [Related]
40. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
